Podcast Episodes
Back to SearchImproving the efficiency of drug approvals in MDS
Episode 156
In recent years, the treatment and management of myelodysplastic syndromes (MDS) has improved, and several clinical trials are investigating novel co…
4 years ago
Highlights from the 2022 Texas MPN Workshop: advances in MPN treatment
Myeloproliferative neoplasms (MPNs) represent a group of rare and heterogeneous diseases which remain a challenge to treat. Several advances have bee…
4 years ago
Highlights from the 2022 Texas MPN Workshop: advances in MPN treatment
Episode 155
Myeloproliferative neoplasms (MPNs) represent a group of rare and heterogeneous diseases which remain a challenge to treat. Several advances have bee…
4 years ago
The need for more effective first-line therapies in MDS
The treatment and management of myelodysplastic syndromes (MDS) remains a challenge due to the heterogeneity of the disease, and early diagnosis and …
4 years ago
The need for more effective first-line therapies in MDS
Episode 154
The treatment and management of myelodysplastic syndromes (MDS) remains a challenge due to the heterogeneity of the disease, and early diagnosis and …
4 years ago
Myeloma 2022: day two highlights
There were several fascinating sessions and discussions at the Myeloma 2022 meeting that took place in Scottsdale, AZ. Topics that were covered inclu…
4 years, 1 month ago
Myeloma 2022: day two highlights
Episode 153
There were several fascinating sessions and discussions at the Myeloma 2022 meeting that took place in Scottsdale, AZ. Topics that were covered inclu…
4 years, 1 month ago
The promise of CAR-T therapy in CLL and challenges in the field
The treatment landscape of chronic lymphocytic leukemia (CLL) has greatly transformed over the years with the introduction of several agents, includi…
4 years, 1 month ago
The promise of CAR-T therapy in CLL and challenges in the field
Episode 152
The treatment landscape of chronic lymphocytic leukemia (CLL) has greatly transformed over the years with the introduction of several agents, includi…
4 years, 1 month ago
Clonal hematopoiesis and pre-MDS states
The relationship between mutations and precursor states in myelodysplastic syndromes (MDS) is a growing area of research, and advances in next-genera…
4 years, 1 month ago